News & Perspective

Jan 28, 2011

Jan 28, 2011

Experts air kinks in antiviral use during H1N1 pandemic

(CIDRAP News) – Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.

Jan 27, 2011

Jan 27, 2011

CDC officials share key pandemic communications lessons

(CIDRAP News) – Two federal officials who frequently appeared on television as top sources during the 2009 H1N1 pandemic provided a rare glimpse behind the curtain at some of the event's pivotal moments today during a panel discussion at an infectious disease conference in Washington, DC.

Sep 20, 2010

Sep 20, 2010

CDC finalizes flu prevention guidance for health settings

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) recently issued new guidance for preventing flu in healthcare settings that reflects a year's worth of new information about the 2009 H1N1 virus and recommends surgical masks rather than N-95 respirators when providing routine care for flu patients.

Jun 23, 2010

Jun 23, 2010

CDC proposes new flu guidance for healthcare facilities

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) yesterday posted updated proposed guidance for preventing pandemic H1N1 and seasonal influenza in healthcare settings, which relaxes some respiratory protection advice and stops short of recommending mandatory flu shots for healthcare workers.

Jun 23, 2010

As EUAs expire, HHS says pandemic emergency is over

(CIDRAP News) – Federal officials today allowed the public health emergency declaration that was prompted by the H1N1 influenza outbreak last year to lapse, signaling an end to emergency authorizations for certain special uses of antiviral drugs and other items.

Apr 23, 2010

Apr 23, 2010

H1N1 LESSONS LEARNED Pandemic underscored influenza's unpredictability

Editor's Note: This is the first of a series of articles reviewing the world's experience with pandemic H1N1 influenza and what we've learned in the past year. Look for further installments in the days to come.

(CIDRAP News) – A year's experience with the 2009 H1N1 influenza virus has underscored the endless unpredictability of flu.

Nov 10, 2009

Nov 10, 2009

NIOSH says disputed study didn't guide advice on masks

Editor's note: This story was revised after initial posting to specify which arm of the CDC issued the statement described.

(CIDRAP News) – Officials at the Centers for Disease Control and Prevention (CDC) yesterday rejected a contention from several professional groups that its guidance on respiratory protection for healthcare workers caring for H1N1 patients was influenced by a recent controversial study by Australian researchers.

Nov 05, 2009

Nov 05, 2009

Reanalysis changes findings in respiratory protection study

A reanalysis prompted by reviewers has changed the conclusions of a study comparing N-95 respirators with surgical masks, raising questions about earlier findings that the N-95 devices were clearly more effective in protecting healthcare workers from respiratory illness.

Oct 26, 2009

Oct 26, 2009

Emergency authorization for peramivir draws fast response

(CIDRAP News) – Requests to use the intravenous (IV) antiviral drug peramivir in hospitalized H1N1 flu patients came quickly after the government issued an emergency use authorization (EUA) Oct 23, a Centers for Disease Control and Prevention (CDC) official said today.

Sep 15, 2009

Sep 15, 2009

Studies suggest novel H1N1 patients shed virus longer

(CIDRAP News) – A new study suggests that patients infected with pandemic H1N1 influenza can transmit the live virus longer than previously thought, though it's not clear if the findings will lead to changes in self-isolation recommendations.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»